Updates
-
-
#ECTRIMS2018 – Blood Level of Neurofilament Light Chain May Predict Brain Atrophy in Progressive MS, Study Suggests
Measuring the blood level of neurofilament light chain (NfL) may predict brain shrinkage in primary progressive (PPMS) and secondary progressive ... Read more -
#ECTRIMS2018 – Stem Cell Transplant Effectively Lessens Disability in Patients with Aggressive MS, Study Finds
Treatment with autologous hematopoietic stem cell transplant (aHSCT) led to a safe and rapid lessening of disability and no clinical ... Read more -
#ECTRIMS2018 – Evobrutinib Seen to Lower Active Brain Lesions in Phase 2 Trial
Merck KGaA announced that evobrutinib, its oral candidate for relapsing multiple sclerosis (MS), was able to safely and significantly reduce active ... Read more -
MS Does Not Excuse Poor Behavior
This is a difficult column to pen. I am an open heart, yet critically examining myself, and my troubling behavior is ... Read more -
#ECTRIMS2018 – Shifting from Gilenya to Lemtrada Doesn’t Increase Risk of MS Reactivation, Study Says
Shifting from treatment with Gilenya (fingolimod) to Lemtrada (alemtuzumab), and doing a short washout period between the ... Read more
-
-
#ECTRIMS2018 – Evobrutinib and Other Reasons for Hope in Pursuit of MS Treatments, Jerry Wolinsky Says in Interview
Advances in multiple sclerosis research and the development of new treatments over ... -
#ECTRIMS2018 – MS PATHS Just Starting to See Potential, Aims for Remission as Treatment Goal, Biogen Exec Says
MS PATHS, a way of capturing data on disease progression and ... -
#ECTRIMS2018 – Two European Studies Compare Tecfidera, Aubagio Effectiveness
Treatment of relapsing-remitting multiple sclerosis (RRMS) patients with Tecfidera (dimethyl fumarate) is ... -
#ECTRIMS2018 – Study Examines Relapses When Stopping Gilenya During, After Pregnancy
Up to half of women with multiple sclerosis (MS) who stop ... -
PPMS Suddenly and Spontaneously Surges My Symptoms
When I was diagnosed in 2010 with primary progressive multiple sclerosis ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
1st Patient Enrolled in Study of Electrical Stimulation in Treating Brain Injury
News
A first patient has been enrolled in a single-site trial to evaluate the potential of electrical stimulation, called Electroceutical Therapy, in reducing brain injury, Endonovo Therapeutics, the therapy’s developer, announced. Electroceutical Therapy is a non-invasive and wearable electronic device ... Read more